TER.CN - TerrAscend Corp.

Canadian Sec - Canadian Sec Delayed Price. Currency in CAD
2.6700
-0.1300 (-4.64%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close2.8000
Open2.7200
Bid2.6000 x 0
Ask2.7000 x 0
Day's Range2.6500 - 2.7900
52 Week Range2.6500 - 9.1800
Volume75,591
Avg. Volume54,483
Market Cap142.493M
Beta (3Y Monthly)0.28
PE Ratio (TTM)N/A
EPS (TTM)-0.4500
Earnings DateAug 22, 2019
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    TerrAscend Announces Agreement on Two Year Term Loan and Extension to Credit Facility

    TORONTO , Dec. 2, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend") the first and only global cannabis company licensed for sales in Canada , the US, and the EU, today announced that it has (i) extended the maturity date of its US$75 million credit facility due December 18, 2019 with funds managed by JW Asset Management LLC for up to three months and (ii) executed a term sheet with funds managed by JW Asset Management LLC to convert any amounts outstanding under the credit facility into a two-year term loan with an expected maturity of March, 2022. Jason Wild, Chairman of the Board of TerrAscend, is the President and Chief Investment Officer at JW Asset Management. In conjunction with the term sheet to convert the credit facility into a term loan, the credit facility maturity has been extended to March 15, 2020 or until such time as the parties have completed the required documentation to commence the conversion.

  • Ted Baker shares tumble after disclosing overvalued inventory
    MarketWatch

    Ted Baker shares tumble after disclosing overvalued inventory

    Shares in Ted Baker took another beating on Monday after the beleaguered British retailer disclosed that its inventory had been overvalued

  • CNW Group

    Chairman Jason Wild Acquires Shares of TerrAscend

    Chairman Jason Wild Acquires Shares of TerrAscend

  • CNW Group

    TerrAscend Closes Third Tranche of Non-Brokered Private Placement

    TORONTO , Nov. 26, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the US, and the EU, today announced it has closed the third tranche of the previously announced non-brokered private placement of units of TerrAscend (the "Offering") for additional gross proceeds of approximately $2.65 million . Each unit in the Offering is comprised of one unsecured convertible debenture of TerrAscend Canada Inc. ("TerrAscend Canada") and 25.2 common share purchase warrants of TerrAscend. The Company previously closed a first tranche of the Offering for gross proceeds of US$10 million and a second tranche of approximately $4.76 million , which were units comprised of unsecured convertible debentures and warrants of TerrAscend.

  • CNW Group

    TerrAscend Announces Strong Revenue Growth and Margin Improvement for the Third Quarter of 2019

    TerrAscend Announces Strong Revenue Growth and Margin Improvement for the Third Quarter of 2019

  • CNW Group

    TerrAscend Closes on Second Tranche of Non-Brokered Private Placement of Unsecured Convertible Debentures and Warrants

    TORONTO , Nov. 7, 2019 /CNW/ - TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the US, and the EU, today announced it has closed the second tranche of the previously announced non-brokered private placement of units of of TerrAscend (the "Offering") for additional gross proceeds of approximately $4.76 million . Each unit in the Offering is comprised of one unsecured convertible debenture and 25.2 common share purchase warrants of TerrAscend. The Company previously closed a first tranche of the Offering for gross proceeds of US$10 million , consisting of a lead order from Canopy Rivers Inc. ("Canopy Rivers") (TSX: RIV, OTC: CNPOF).

  • CNW Group

    TerrAscend Names Jason Ackerman Executive Chairman and Provides Business Update

    TerrAscend Names Jason Ackerman Executive Chairman and Provides Business Update

  • CSE & OTC Markets Cannabis Investor Conference Now Available for On-Demand Viewing
    PR Newswire

    CSE & OTC Markets Cannabis Investor Conference Now Available for On-Demand Viewing

    Public Cannabis Company Executives shared vision, answered questions at VirtualInvestorConferences.com NEW YORK , Nov. 1, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with the Canadian ...

  • PR Newswire

    CSE & OTC Markets Cannabis Live-Stream Investor Conference & Webinar October 30th

    Public Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com NEW YORK , Oct. 23, 2019 /PRNewswire/ -- Virtual Investor Conferences, in partnership with the Canadian ...

  • CNW Group

    TerrAscend Forms Brokerage Partnership with Kindred Partners, Inc.

    OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the US, and the EU, announced today that it has formed a strategic partnership with Kindred Partners Inc. ("Kindred"), a specialty cannabis brokerage and services company, where Kindred will serve as the exclusive broker for TerrAscend's adult-use cannabis products in Canada . The agreement will help bolster distribution and drive sales for TerrAscend by leveraging Kindred's brokerage, marketing and brand-building services, as well as its consumer insights and data. Kindred, a wholly-owned subsidiary of Breakthru Beverage Group, LLC, has deep roots and significant experience in effectively managing distribution agreements in highly-regulated industries.

  • PR Newswire

    TerrAscend Canada Receives License to Sell Cannabis Extracts, Topicals and Edibles

    OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada, the US, and the EU, today announced that it has received an amendment to its license from Health Canada to allow it to sell cannabis extracts, topicals and edibles from its EU-GMP certified facility in Mississauga, Ontario. Sales of TerrAscend's new product formats will begin in December, pending Health Canada authorization. The company submitted 15 SKUs to Health Canada, including edibles, vape pens, and cartridges, to be to be authorized for launch this year.

  • Newsfile

    OTC Markets Group & Canadian Securities Exchange to Cohost Cannabis Investor Day at OTC Markets Group's 300 Vesey Street NY Headquarters

    Investors, Entrepreneurs and Publicly-Traded Cannabis Companies Convene to Discuss the Current State of the Cannabis Industry New York, New York--(Newsfile Corp. - October 15, 2019) - OTC Markets Group Inc. (OTCQX: OTCM), operator of financial markets for 10,000 U.S. and global securities, and the Canadian Securities Exchange (CSE), a Canadian listing exchange, announced that they will host a Cannabis Investor Day at OTC Markets Group's New York City headquarters on Wednesday, October 30, 2019. The ...

  • OTC Markets Group & Canadian Securities Exchange to Cohost Cannabis Investor Day at OTC Markets Group's 300 Vesey Street NY Headquarters
    PR Newswire

    OTC Markets Group & Canadian Securities Exchange to Cohost Cannabis Investor Day at OTC Markets Group's 300 Vesey Street NY Headquarters

    Investors, Entrepreneurs and Publicly-Traded Cannabis Companies Convene to Discuss the Current State of the Cannabis Industry NEW YORK , Oct. 15, 2019 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), ...

  • CNW Group

    TerrAscend Canada Triples Licensed Cultivation and Processing Capacity

    --- Health Canada's approval of additional licensed space at Mississauga, Ontario facility provides significant scale in production and processing. --- Newly licensed processing operations readies TerrAscend for Canadian Cannabis 2.0 implementation. OTCQX: TRSSF) ("TerrAscend" or "the Company"), the first and only global cannabis company licensed for sales in Canada , the US, and the EU, today announced that it has received approval from Health Canada for significant expansion at its facility in Mississauga, Ontario .